3 Followers on Owler
Mink is a New York-based clinical-stage biopharmaceutical company that researches and develops iNKT cell therapies for the treatment of cancer and immune-mediated diseases... Read more
OverviewCompetitorsFundingNews & Insights
Mink is a New York-based clinical-stage biopharmaceutical company that researches and develops iNKT cell therapies for the treatment of cancer and immune-mediated diseases... Read more
MiNK Therapeutics President & CEO: Jennifer S. Buell

President & CEO

Jennifer S. Buell

CEO Approval Rating

90/100

2017

PublicIndependent CompanyNASDAQINKT

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology

Annual Revenue
<$1M
Employees
30
Funding
$45.8M

News

Funding
May 13, 2024
GlobalNewswire
MiNK Therapeutics received $5.8M in PIPE Funding

MiNK Therapeutics Competitors

1GRI Bio
2Portage
3Allogene
4Atara
5CRISPR
Unlock 2 + competitors

Trending Companies